Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia
· Delayed Price · Currency is AUD 0.0280
+0.0020 (7.69%)
May 14, 2025, 4:10 PM AEST
ASX:LDX Market Cap
ASX:LDX has a market cap or net worth of 19.46 million as of May 14, 2025. Its market cap has decreased by -29.06% in one year.
Market Cap
19.46M
Enterprise Value
23.14M
Revenue
23.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 5, 2021, ASX:LDX's market cap has decreased from 196.70M to 19.46M, a decrease of -90.11%. That is a compound annual growth rate of -45.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 19.46M | -25.71% |
| Dec 31, 2024 | 26.20M | -25.44% |
| Dec 29, 2023 | 35.13M | 248.53% |
| Dec 30, 2022 | 10.08M | -93.27% |
| Dec 31, 2021 | 149.80M | -23.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.59B |
| Pro Medicus | 26.55B |
| Cochlear | 17.38B |
| Sonic Healthcare | 12.72B |
| Ramsay Health Care | 8.39B |
| Telix Pharmaceuticals | 8.27B |
| Ansell | 4.61B |
| Regis Healthcare | 2.33B |